These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 989639

  • 1. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
    Hedner U, Nilsson IM, Bergentz SE.
    Thromb Haemost; 1976 Apr 30; 35(2):386-95. PubMed ID: 989639
    [Abstract] [Full Text] [Related]

  • 2. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
    MacGregor IR, Ferguson JM, McLaughlin LF, Burnouf T, Prowse CV.
    Thromb Haemost; 1991 Nov 01; 66(5):609-13. PubMed ID: 1803625
    [Abstract] [Full Text] [Related]

  • 3. [The action of peanut extract on the blood coagulation system].
    Novak EN.
    Farmakol Toksikol; 1966 Nov 01; 29(5):568-71. PubMed ID: 5995068
    [No Abstract] [Full Text] [Related]

  • 4. Biochemical and in vivo properties of high purity factor IX concentrates.
    Berntorp E, Björkman S, Carlsson M, Lethagen S, Nilsson IM.
    Thromb Haemost; 1993 Nov 15; 70(5):768-73. PubMed ID: 8128433
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C, Menart C, Attali O, Petit PY, Lienhart A, Dechavanne M, Ingerslev J.
    Blood Coagul Fibrinolysis; 1998 Mar 15; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [Abstract] [Full Text] [Related]

  • 6. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence.
    Grundman C, Plesker R, Kusch M, Hanschmann KM, Eich S, Seitz R, König H.
    Thromb Haemost; 2005 Dec 15; 94(6):1338-9. PubMed ID: 16411418
    [No Abstract] [Full Text] [Related]

  • 7. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
    McLaughlin LF, Drummond O, MacGregor IR.
    Thromb Haemost; 1992 Nov 10; 68(5):511-5. PubMed ID: 1455396
    [Abstract] [Full Text] [Related]

  • 8. [The effect of aminazine on blood coagulation].
    Novak EN.
    Farmakol Toksikol; 1972 Nov 10; 35(6):717-20. PubMed ID: 4651808
    [No Abstract] [Full Text] [Related]

  • 9. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
    Pechet L, Groth CG, Daloze PM.
    J Lab Clin Med; 1969 Jan 10; 73(1):91-102. PubMed ID: 4883102
    [No Abstract] [Full Text] [Related]

  • 10. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.
    J Lab Clin Med; 1993 Mar 10; 121(3):394-405. PubMed ID: 8445288
    [Abstract] [Full Text] [Related]

  • 11. [Effect of calcium chloride on blood coagulation].
    Novak EN, Iadrova VM.
    Farmakol Toksikol; 1967 Mar 10; 30(2):192-5. PubMed ID: 5599523
    [No Abstract] [Full Text] [Related]

  • 12. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.
    Köhler M, Hellstern P, Lechler E, Uberfuhr P, Müller-Berghaus G.
    Thromb Haemost; 1998 Sep 10; 80(3):399-402. PubMed ID: 9759617
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B, Piecuch W, Walter-Croneck A, Dmoszyńska A, Furmanik F.
    Przegl Lek; 2002 Sep 10; 59(7):502-8. PubMed ID: 12516238
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 10; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 15. Potentially thrombogenic materials in factor IX concentrates.
    Kingdon HS, Lundblad RL, Veltkamp JJ, Aronson DL.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):617-31. PubMed ID: 1154317
    [Abstract] [Full Text] [Related]

  • 16. Prothrombin complex concentrates for clinical use.
    Chandra S, Brummelhuis HG.
    Vox Sang; 1981 Jun 30; 41(5-6):257-73. PubMed ID: 6798760
    [Abstract] [Full Text] [Related]

  • 17. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S, Cattaneo M, Gervasoni W, Mannucci PM.
    Thromb Haemost; 1980 Oct 31; 44(2):72-5. PubMed ID: 6779400
    [Abstract] [Full Text] [Related]

  • 18. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs.
    Cash JD, Dalton RG, Middleton S, Smith JK.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):632-9. PubMed ID: 1154318
    [No Abstract] [Full Text] [Related]

  • 19. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M, Lowe GD, Douglas JT, Forbes CD, Prentice CR.
    Thromb Haemost; 1982 Aug 24; 48(1):76-7. PubMed ID: 7135346
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.